US Dollar vs Yen

登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。

ホーム
投資
株式
オーストラリア
ASX
Greentech Metals Ltd (GRE) 銘柄情報

Greentech Metals Ltd (GRE)

0.076

-0.004

(-5.00%)

終了 6月7日 3:00PM

Greentech Metals Ltd (GRE) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.076

( -5.00% )

買値

0.076

売値

0.08

出来高

219,378

0.076 日の範囲 0.076

0.039 52 週間の範囲 0.16

時価総額

前日終値

0.08

始値

0.076

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

AUD 976,901

発行済株式数

324,502,954

配当利回り

PER

-0.81

1 株当たり利益 (EPS)

-0.09

歳入

2.02k

純利益

-10.58M

GreenTech Metals Limited engages in the exploration, development, and evaluation of mineral properties in Western Australia. The company explores for nickel, copper, zinc, gold, lithium, cobalt, platinum group element, and base metal deposits. GreenTech Metals Limited was incorporated in 2021 and is... GreenTech Metals Limited engages in the exploration, development, and evaluation of mineral properties in Western Australia. The company explores for nickel, copper, zinc, gold, lithium, cobalt, platinum group element, and base metal deposits. GreenTech Metals Limited was incorporated in 2021 and is based in West Perth, Australia. 詳細を表示

セクター

Materials

業界

Mining

ウェブサイト

greentechmetals.com

本社

West Perth, Australia

設立

2026

Greentech Metals Ltd is listed in the Materials sector of the オーストラリア証券取引所 with ticker GRE. The last closing price for Greentech Metals was AUD0.08. Over the last year, Greentech Metals shares have traded in a share price range of AUD 0.039 to AUD 0.16.

Greentech Metals currently has 324,502,954 shares in issue. The market capitalisation of Greentech Metals is AUD24.66 million. Greentech Metals has a price to earnings ratio (PE ratio) of -0.81.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	-0.006	-7.31707317073	0.082	0.083	0.073	1155794	0.07688183	DE
4	-0.005	-6.17283950617	0.081	0.093	0.071	1587468	0.077968	DE
12	-0.016	-17.3913043478	0.092	0.094	0.06	962842	0.07684863	DE
26	-0.001	-1.2987012987	0.077	0.16	0.06	1060534	0.10309953	DE
52	0.032	72.7272727273	0.044	0.16	0.039	679808	0.09404466	DE
156	-0.044	-36.6666666667	0.12	0.99	0.039	644982	0.30428224	DE
260	-0.214	-73.7931034483	0.29	0.99	0.039	591068	0.28985978	DE

GRE - Frequently Asked Questions (FAQ)

What is the current Greentech Metals Ltd share price?

The current share price of Greentech Metals Ltd is AUD 0.076

How many Greentech Metals Ltd shares are in issue?

Greentech Metals Ltd has 324,502,954 shares in issue

What is the market cap of Greentech Metals Ltd?

The market capitalisation of Greentech Metals Ltd is AUD 24.66M

What is the 1 year trading range for Greentech Metals Ltd share price?

Greentech Metals Ltd has traded in the range of AUD 0.039 to AUD 0.16 during the past year

What is the PE ratio of Greentech Metals Ltd?

The price to earnings ratio of Greentech Metals Ltd is -0.81

What is the cash to sales ratio of Greentech Metals Ltd?

The cash to sales ratio of Greentech Metals Ltd is 10.34k

What is the registered address of Greentech Metals Ltd?

The registered address for Greentech Metals Ltd is 10 Ord Street, West Perth, Western Australia, 6005

What is the Greentech Metals Ltd website address?

The website address for Greentech Metals Ltd is greentechmetals.com

Which industry sector does Greentech Metals Ltd operate in?

Greentech Metals Ltd operates in the Mining sector

DTGoody

DTGoody 2分前

Yes, I was playing that Damn VMH* which appears I jinxed as usual! That's another one pissing me off! LOL I could have bought a ton more shares here if I reacted better to the news and switched things around if you know what I mean. Instead, I had my thumb up my Rear while this Gem keeps running! LO

Myth

Hand Of Fate · The Rolling Stones

https://www.youtube.com/watch?v=3RGhtDjup38

badshah

badshah 3分前

School teacher...but you have no shares...so why the interest????

dewophile

dewophile 4分前

I’ll check it out thanks. A key point is that ketones can rise even when glucose levels are within range. I’m not sure the commercial opportunity but it sounds not only limited to type 1 diabetics. It also seems like dexcom has greater market share in intensive insulin users and this is the populati

Myth

The Rolling Stones - One Hit (To The Body)

https://www.youtube.com/watch?v=dx2WRQLSIew

1plus1

A Once in a lifetime opportunity, BIEI will make history next week in Mexico, World Cup and we sponsor the product … possible dream come true

jerkviewer

jerkviewer 4分前

i would love to know what he thinks our chances are

jerkviewer

jerkviewer 5分前

it might not be such a longshot....it definitely would change the valuation....nas will hopefully expand on that topic on the cc

eur06

ok it’ll be fine to wait, no rush from me.
GLND

1plus1

LET'S HOPE THEY WILL USE THE PRODUCTS IN FIFFA CUP NEXT WEEK >> THIS WILL BE SWEEEEEEEEEEET AND OVER .10+ CENTS

FOFreddie

FOFreddie 10分前

Ackman is a billionaire friend who would probably this resolved ASAP. John Paulson is a billionaire friend who also probably wants this resolved ASAP. They really need to come out with a Housing Plan ASAP as you mentioned. Also - why would Trump want to leave any money on the table for the nex

DTGoody

DTGoody 10分前

Why would Cohen be involved with ENCC??? I'm sorry, but I don't see the connection between him and ENCC.

DTGoody

DTGoody 12分前

We will be on entirely differently exchange then!

flipper44

flipper44 12分前

NWBO was entrusted with this technology well over decades ago. Their perseverance is commendable, but their execution, communication, morphing plans, spending, and red zone efficiency, and that of MHRA, are reasonably subject to scrutiny.

GR8 Dad

GR8 Dad 12分前

If you ride the o t c you're gonna lose some money, even a child knows that.

Make sure your winners are bigger than your losers.That's the only way to play it.

The o t c is the world's largest casino, where the only game is liars poker.

Riding many, many,

Myth

Blow Wind Blow · Eric Clapton

https://www.youtube.com/watch?v=aE-QoPDxijc

DewDiligence

DewDiligence 13分前

Berobenatide—dosed monthly—appears_competitive_with_weekly Zepbound/Wegovy in efficacy/tolerability—see slide 7 at the link in #msg-177679183.

Berobenatide (f/k/a ‘3944) is the lead compound from PFE’s weight-loss pipeline acquired in the Metsera buyout (#msg-176942527).

joe botts

joe botts 14分前

tisdal

tisdal 15分前

Nice Job on the Research CW. That opened my eyes to truly understand what the GARB Report's purpose was. That GARB Report was a preliminary document to establish hydrocarbon potential justifying the 3D Seismic, and after analyzing that data, if drilling would be justifiable.

The sta

FOFreddie

FOFreddie 16分前

The Brydon Fisher lawsuit was a Derivative lawsuit which would have returned the damages back to Fannie and Freddie for the benefit of shareholders. The Lamberth/Berkeley lawsuit is a Class Action but the issue so far is that damages were severely limited. We wait for the Decision on Restitution

DewDiligence

DewDiligence 19分前

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

jour_trader

jour_trader 19分前

Would certainly be astronomical, just don’t think the odds are in our favor. We’ll know soon enough via lawsuit or cc if paragraph IV was pursued.

DewDiligence

DewDiligence 20分前

ABT dual glucose/ketone CGMs facilitate_early_detection_of diabetic ketoacidosis (DKA):

https://www.prnewswire.com/news-releases/new-abbott-data-show-many-people-with-diabetes-may-not-recognize-symptoms-of-diabetic-ketoacidosis-302793024.html Findings from multiple Abbott studies sha

JamesF1

JamesF1 20分前

I look at the possibility of Elite successfully getting a paragraph 4 approval for Eliquis as a long shot. Long shots occasionally come in.

Greentech Metals

Advanced Powerline Techn... (EM)

Pepper I Prime 2017 3

4000% until 01/11/2035

S&P ASX 200 Futures 4.5%...

Starwood Property

Capital Clean Energy Car...

Bank Of America

Franklin MSCI Emer Marke...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。